Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TScan Therapeutics (TCRX) Debt Ratio (2022 - 2025)

TScan Therapeutics (TCRX) has disclosed Debt Ratio for 4 consecutive years, with 0.14 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 64.55% to 0.14 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14 through Dec 2025, up 64.55% year-over-year, with the annual reading at 0.14 for FY2025, 64.55% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.14 at TScan Therapeutics, up from 0.12 in the prior quarter.
  • The five-year high for Debt Ratio was 0.18 in Q3 2022, with the low at 0.08 in Q2 2024.
  • Average Debt Ratio over 4 years is 0.12, with a median of 0.11 recorded in 2025.
  • The sharpest move saw Debt Ratio tumbled 41.52% in 2023, then skyrocketed 64.55% in 2025.
  • Over 4 years, Debt Ratio stood at 0.15 in 2022, then decreased by 24.95% to 0.11 in 2023, then fell by 21.73% to 0.09 in 2024, then surged by 64.55% to 0.14 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.14, 0.12, and 0.11 for Q4 2025, Q3 2025, and Q2 2025 respectively.